Cetera Advisor Networks LLC Day One Biopharmaceuticals, Inc. Transaction History

Cetera Advisor Networks LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 14, 2024	BUY	$13.56 - $17.46 $30,089 - $38,743	2,219 Added 8.9%	27,165 $448,000
Q4 2023 Feb 13, 2024	SELL	$9.68 - $15.37 $26,068 - $41,391	-2,693 Reduced 9.74%	24,946 $364,000
Q3 2023 Nov 14, 2023	BUY	$11.22 - $14.86 $181,079 - $239,825	16,139 Added 140.34%	27,639 $339,000
Q2 2023 Aug 09, 2023	BUY	$11.74 - $14.47 $17,610 - $21,705	1,500 Added 15.0%	11,500 $137,000
Q1 2023 May 15, 2023	BUY	$12.75 - $23.41 $127,500 - $234,100	10,000 New	10,000 $133,000

178

84M

144K

218K

Ticker DAWN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 73,461,104
Market Cap $940M
Description
Day One Biopharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops and commercializes targeted therapies for patients with genetically defined cancers. Its lead product candidate is DAY101, an oral brain-penetrant type II pan-rapidly accelerated fibrosarcoma kinase inhibitor that is in Phase II clinical trial for pediatric pa...

Get notified when there are updates to the investment portfolio of Cetera Advisor Networks LLC, based on Form 13F filings with the SEC.

Stay updated on Cetera Advisor Networks LLC with notifications on news.